Qualigen Therapeutics

Yahoo Finance • 6 days ago

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial t... Full story

Yahoo Finance • 7 days ago

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Finalizes U.S. Production Assembly Plan

FF has finalized the U.S. production assembly plan for FX Super One. The Company’s bridge partners and supply chain collaborators will now commence component supply for the production assembly phase. This week, FF successfully closed a str... Full story

Yahoo Finance • 12 days ago

Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)

New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of $41 mill... Full story

Yahoo Finance • 13 days ago

Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto

Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or “the Company”) today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by... Full story

Yahoo Finance • 13 days ago

Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy

QLGN is expected to rebrand as CXC10 soon, reflecting its new strategic direction around crypto and web3 business. LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”... Full story

Yahoo Finance • 20 days ago

This Penny Stock Is Surging Big Time on a Tie-Up With Faraday Future and a Push Into Crypto. Should You Buy Its Shares Here?

Qualigen Therapeutics (QLGN) [https://www.barchart.com/quotes/QLGN] shares soared about 200% on Monday at the peak after the biotech company secured a $41 million investment from Faraday Future (FFAI) [https://www.barchart.com/quotes/FFAI]... Full story

Yahoo Finance • 21 days ago

Qualigen To Focus On Driving Growth In Crypto, Web3 - Stock Surges 200%

(RTTNews) - Shares of Qualigen Therapeutics Inc. (QLGN) are up over 200% in premarket trading on Monday, following a $41 million strategic investment by Faraday Future Intelligent Electric Inc. (FFAI), a California-based global shared inte... Full story

Yahoo Finance • 21 days ago

Faraday Future announces investment of $41M in Qualigen Therapeutics

* Faraday Future (NASDAQ:FFAI [https://seekingalpha.com/symbol/FFAI]) said on Sunday that it is strategically investing [https://seekingalpha.com/pr/20239048-faraday-future-announced-a-total-strategic-investment-of-41-million-in-qualigen... Full story

Yahoo Finance • 21 days ago

Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines

Faraday Future is making an investment of approximately $30 million in Qualigen Therapeutics (“QLGN”); FF Founder and Co-CEO YT Jia will invest approximately $4 million (via an FFGP loan) in QLGN with a two-year lockup.The strategic invest... Full story

Yahoo Finance • 23 days ago

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction

LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem... Full story

Yahoo Finance • 23 days ago

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction

LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company,... Full story

Yahoo Finance • 3 months ago

Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, L... Full story

Yahoo Finance • 3 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential... Full story

Yahoo Finance • 3 months ago

Qualigen Therapeutics secures global patents for cancer drug QN-302

CARLSBAD, Calif. - Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a small-cap biotech with a market capitalization of $5.77 million, announced Wednesday that it has secured multiple patents for its cancer drug QN-302 across Europe, India, Chin... Full story

Yahoo Finance • 3 months ago

Qualigen Granted New Patents Covering 25 Countries

Qualigen Therapeutics, Inc. CARLSBAD, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company” or “Qualigen”) is announcing an update on patents granted in the first six months of 2025. The paten... Full story

Yahoo Finance • 5 months ago

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq... Full story

Yahoo Finance • 2 years ago

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Initiated dosing of three patients in first cohort of Phase 1 clinical trial of QN-302 for treatment of advanced or metastatic solid tumorsPhase 1a patient recruitment ongoing; company anticipates sharing update on safety and preliminary e... Full story

Yahoo Finance • 2 years ago

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designa... Full story

Yahoo Finance • 2 years ago

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer

Poster Includes Preclinical Data on Pan-RAS Compounds Demonstrating Inhibition in Breast Cancer Models CARLSBAD, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company... Full story

Yahoo Finance • 2 years ago

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023

Two posters include data on potential clinical biomarkers and transcriptomic data associated with QN-302’s mechanism of action CARLSBAD, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-s... Full story